393 related articles for article (PubMed ID: 27424295)
1. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
2. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
3. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
[TBL] [Abstract][Full Text] [Related]
4. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
5. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
6. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
Leufkens TR; Vermeeren A
J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control: Study Protocol Clinical Trial (SPIRIT Compliant).
Iwata M; Iwamoto K; Kambe D; Tachibana N; Ando M; Ozaki N
Medicine (Baltimore); 2020 Mar; 99(12):e19395. PubMed ID: 32195934
[TBL] [Abstract][Full Text] [Related]
8. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
[TBL] [Abstract][Full Text] [Related]
9. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443
[TBL] [Abstract][Full Text] [Related]
10. Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers.
Iwamoto K; Iwata M; Kambe D; Imadera Y; Tachibana N; Kajiyama Y; Ando M; Ozaki N
Psychopharmacology (Berl); 2022 Mar; 239(3):841-850. PubMed ID: 35106620
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning.
Bland H; Li X; Mangin E; Yee KL; Lines C; Herring WJ; Gillespie G
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):414-420. PubMed ID: 34181362
[TBL] [Abstract][Full Text] [Related]
12. Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.
Verster JC; Spence DW; Shahid A; Pandi-Perumal SR; Roth T
Curr Drug Saf; 2011 Sep; 6(4):209-18. PubMed ID: 22129315
[TBL] [Abstract][Full Text] [Related]
13. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
Leufkens TR; Vermeeren A
Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
[TBL] [Abstract][Full Text] [Related]
14. Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.
Uemura N; McCrea J; Sun H; Donikyan M; Zammit G; Liu R; Louridas B; Marsilio S; Lines C; Troyer MD; Wagner J
J Clin Pharmacol; 2015 Oct; 55(10):1093-100. PubMed ID: 25903940
[TBL] [Abstract][Full Text] [Related]
15. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
16. Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials: NMA driving and hypnotics.
Fornaro M; Caiazza C; Rossano F; Cilmi F; De Prisco M; Vieta E; Thompson T; Solmi M; Carvalho AF; Iasevoli F; de Bartolomeis A
Eur Neuropsychopharmacol; 2024 Apr; 81():53-63. PubMed ID: 38401406
[TBL] [Abstract][Full Text] [Related]
17. Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.
Ma J; Svetnik V; Snyder E; Lines C; Roth T; Herring WJ
Sleep; 2014 Oct; 37(10):1609-19. PubMed ID: 25197807
[TBL] [Abstract][Full Text] [Related]
18. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
19. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
20. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
